99734-97-1 Usage
Chemical class
Fluoroquinolone antibiotics
Cyclopropyl group
A three-carbon ring structure attached to the compound
Pyrrolidinyl group
A five-carbon ring structure with one nitrogen atom
Ethylamino group
An ethyl group attached to an amine group
Fluorine atoms
Two fluorine atoms present in the molecule
Quinolone core structure
The central structure of the compound
Target enzyme
DNA gyrase
Mechanism of action
Inhibition of bacterial DNA replication and transcription
Effective against
A wide range of gram-negative and gram-positive bacteria
Treatment of infections
Respiratory, urinary tract, and skin infections
Prescription
Often prescribed under various brand names and formulations by healthcare professionals
Check Digit Verification of cas no
The CAS Registry Mumber 99734-97-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,7,3 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 99734-97:
(7*9)+(6*9)+(5*7)+(4*3)+(3*4)+(2*9)+(1*7)=201
201 % 10 = 1
So 99734-97-1 is a valid CAS Registry Number.
99734-97-1Relevant articles and documents
Antibacterial agents
-
, (2008/06/13)
Novel quinoline-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
Process for quinoline-3-carboxylic acid antibacterial agents
-
, (2008/06/13)
An improved process for the preparation of 7-substituted amino-1-alkyl- or cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids is described where tetrafluorobenzoyl chloride is converted in three operations via 1-alkyl or 1-cycloalkyl-1
Antibacterial agents
-
, (2008/06/13)
Novel naphthyridine-, quinoline- and benzoxazine-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
